CN Patent

CN101638423A — 根皮苷衍生物及其制备方法和用途

Assigned to CHANGZHOU HIGH-TECH INDUSTRIAL DEVELOPMENT ZONE SANWEI INDUSTRY TECHNOLOGY RESEARCH Co Ltd · Expires 2010-02-03 · 16y expired

What this patent protects

本发明提供了具有式(I)的结构通式的根皮苷衍生物，其具有抑制SGLT2的作用。该类化合物制备方法容易，可用于治疗糖尿病及其并发症等代谢类疾病。

USPTO Abstract

本发明提供了具有式(I)的结构通式的根皮苷衍生物，其具有抑制SGLT2的作用。该类化合物制备方法容易，可用于治疗糖尿病及其并发症等代谢类疾病。

Drugs covered by this patent

Jardiance (empagliflozin) · Boehringer Ingelheim

Patent Metadata

Patent number: CN101638423A
Jurisdiction: CN
Classification: —
Expires: 2010-02-03
Drug substance claim: No
Drug product claim: No
Assignee: CHANGZHOU HIGH-TECH INDUSTRIAL DEVELOPMENT ZONE SANWEI INDUSTRY TECHNOLOGY RESEARCH Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.